Novartis’s Canakinumab Fails In COVID-19 Pneumonia Patients
Dexamethasone Remains Only Proven Therapy In Severe Disease
The trial aimed to help hospitalized patients not yet on mechanical ventilation but failed to show an impact on mortality rates. • Source: Archive 
